Related Experiment Videos

Neurological outcome of a patient with Gaucher disease type III treated by enzymatic replacement therapy

D Dobbelaere¹, S Sukno, S Defoort-Dhellemmes

¹Unité des Maladies Métaboliques, Hôpital Jeanne de Flandre, Centre Hospitalier Régional Universitaire de Lille, France.

Journal of Inherited Metabolic Disease

|March 21, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Intrauterine growth restriction, soluble fms-like tyrosine kinase-1 to placental growth factor ratio increase and preeclampsia.

Journal of gynecology obstetrics and human reproduction·2019

Temperature Effects on the Disease Reactions of Sunflower to Infection by Orobanche cumana.

Plant disease·2019

Transition from pediatric to adult care in adolescents with hereditary metabolic diseases: Specific guidelines from the French network for rare inherited metabolic diseases (G2M).

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2018

Wiedemann-Steiner syndrome as a major cause of syndromic intellectual disability: A study of 33 French cases.

Clinical genetics·2018

Optic Nerve Sheath Meningocele: A Case Report.

Neuro-ophthalmology (Aeolus Press)·2017

Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report.

Journal of medical case reports·2016

See all related articles